Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (383)
- Scheduling (national classification system) (169)
- Safety monitoring and information (26)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Medicinal cannabis hub (6)
- Clinical trials (5)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
756 result(s) found, displaying 401 to 425
-
Corporate reportsOverview of therapeutic goods advertising complaints handling and compliance for 2019-20
-
Scheduling submissionsPublic submissions on matters referred to the March 2020 scheduling meetings, and received during the interim consultation period
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 13 October 2020
-
Meeting statementsA meeting of the TGACC was held on 27 August 2020. A communique has been published.
-
TGA laboratory testing reportsTGA Laboratories has released a new report describing our assessment of the 2020 seasonal flu vaccine
-
Meeting statementsAdvisory Committee on Medical Devices (ACMD) meeting statement.
-
Scheduling decisions (final)Public notice of the Delegates' final decisions to amend (or not amend) the Poisons Standard.
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 16 July 2020
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement.
-
Scheduling decisions (interim)Invitation for further comment. Closing date: 28 August 2020
-
Corporate reportsThe independent review is complete and the report now published.
-
Corporate reportsFinal Report on the impact of advertising reforms from the Expert Panel Review of Medicines and Medical Devices Regulation, and other initiatives
-
Meeting statementsAdvisory Committee on Medical Devices (ACMD) meeting 54 statement.
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement.
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement.
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement.
-
Meeting statementsAdvisory Committee on Medical Devices (ACMD) meeting statement.
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Corporate reportsGuidance for reducing assessment fees for ARTG application audits and TGA conformity assessments of medical devices (including IVDs).
-
Corporate reportsA rapid literature review of safety and performance issues.
-
Scheduling decisions (final)Notice of NCE to be included in Schedule 4 of the Poisons Standard
-
TGA Laboratories testing report: Microbiological testing of medicines containing Green-lipped Mussel
TGA laboratory testing reportsTGA Laboratories Branch has released a report summarising the microbiological testing of green-lipped mussel products